N. Christeff et al., EFFECT OF INTERFERON-ALPHA ON HIGH SERUM ANDROGEN CONCENTRATIONS IN HIV-POSITIVE MEN WITH KAPOSIS-SARCOMA, Journal of Clinical Pathology, 50(4), 1997, pp. 341-345
Aim-To measure serum androgen concentrations in men with HIV related K
aposi's sarcoma (KS) who had been treated with recombinant interferon
(IFN) alpha-2a to determine the role of androgens on the development o
f KS lesions. Methods-32 men with HIV related KS who had been treated
with IFN were studied: 24 men in complete KS remission and eight not i
n remission. Serum androgen concentrations were determined before, dur
ing, and after IFN treatment and correlated with clinical remission. R
esults-All patients in complete KS remission had lower serum androgen
concentrations following IFN treatment: -51% for dehydroepiandrosteron
e (DHEA) (p < 0.0001); -38% for DHEA sulphate (p < 0.002); -39% for an
drostenedione (p < 0.002); and -44% for testosterone (p < 0.007). Thes
e decreases brought the serum concentrations to about normal levels. H
owever, IFN had varying effects on serum androgen concentrations in th
e men not in remission: a small decrease, a increase in one androgen,
or no change in serum androgens. Conclusions-The association between s
erum androgen levels and the progression or remission of HIV associate
d KS suggests that androgens affect the development of KS lesions. A c
lear understanding of the changes in the androgen environment may prov
ide a sound basis for the development of new therapeutic strategies.